FDA Moves to Register Overseas Tobacco Makers
Published Date: 6/29/2026
Proposed Rule
Summary
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
Analyzed Economic Effects
7 provisions identified: 1 benefits, 6 costs, 0 mixed.
Foreign Makers Must Register and List
If finalized, owners and operators of foreign establishments that manufacture, prepare, compound, or process tobacco products sold in or offered for import into the United States would have to register their establishments and list their products with FDA. The proposal explicitly extends current registration and listing requirements to foreign establishments under proposed 21 CFR 1108 and would bring parity between domestic and foreign owners/operators.
Foreign Establishments Subject to FDA Inspections
The proposal would make registered foreign establishments subject to FDA inspections under sections 905(g) and 905(h) of the FD&C Act. FDA states that registered foreign establishments would be subject to inspection in support of enforcement and premarket review activities.
More Entities Count as 'Manufacturers'
The proposed rule clarifies that the term 'manufacture' includes specification developers, third-party manufacturers, bulk tobacco product manufacturers, and repackagers/relabelers. As a result, these types of entities would be required to register and list products under the proposed 21 CFR 1108 requirements.
Noncompliance Can Trigger Enforcement Actions
The document states that failure to register, to provide required product listing information, or to provide required notices can constitute prohibited acts under section 301 of the FD&C Act and that violations related to establishment registration and product listing are subject to regulatory action, including civil money penalties, seizure, and injunction.
Electronic Submission Required (Waivers Possible)
The proposed rule would generally require electronic submission of establishment registration and tobacco product listing information, unless FDA grants a waiver. FDA says electronic submission would be used by all registrants and would further the Government Paperwork Elimination Act goals.
New Recordkeeping Requirements for Listed Products
The proposed rule would require owners or operators to maintain a historical file of consumer information, labeling, and advertisements for all tobacco products listed, and to keep records about the distribution of free samples of smokeless tobacco products. These recordkeeping requirements are proposed under sections 905 and 909 of the FD&C Act.
Agency Estimates of Annualized Costs
FDA estimates 20-year annualized total costs to domestic and foreign establishments and FDA would range from $6.80 million to $26.55 million, with a primary estimate of $15.57 million at a 7% discount rate. FDA reports domestic-establishment costs of $0.013 million (primary estimate) and foreign-establishment costs of $0.37 million (primary estimate), with FDA shouldering about 97.5% of total costs in the primary estimate.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
2026-19655, Jeffrey Thies: Final Debarment Order
Jeffrey Thies is banned for 10 years from importing any drugs into the U.S. because he was convicted of trafficking fake drugs. He didn’t respond to the FDA’s notice, so the ban started on September 25, 2026. He can apply to end the ban anytime, but until then, no drug imports for him!
2026-19656, Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2 Inactive Bakers Yeast
The FDA just gave a thumbs-up to using vitamin D2 inactive baker's yeast as a safe way to add vitamin D2 to certain foods. This change helps food makers boost vitamin D in their products, starting September 25, 2026. If anyone has concerns, they have until October 26, 2026, to speak up—no extra costs or hassles expected!
Previous / Next Documents
Previous: 2026-13034, Airworthiness Directives; Airbus Helicopters Deutschland GmbH (AHD) Helicopters
If you own or operate certain Airbus Helicopters Deutschland models, listen up! The FAA wants you to regularly check your tail rotor blades for cracks caused by corrosion and replace any damaged parts to keep flying safe. Comments on this new rule are open until August 13, 2026, so get ready to inspect and possibly spend some bucks to keep your chopper in top shape.
Next: 2026-13054, Fisheries Off West Coast States; Coastal Pelagic Species Fisheries; Annual Specifications; 2026-2027 Annual Specifications and Management Measures for Pacific Sardine
Starting July 1, 2026, most commercial fishing for Pacific sardines off Washington, Oregon, and California will be paused to help the sardine population bounce back. Only limited fishing for live bait, small catches, or special permits will be allowed. This plan sets clear catch limits to protect the fish and supports a healthier ocean and fishing future.